A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

174

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Parkinson's Disease

Interventions

DRUG

SPM 962

SPM 962 transdermal patch once a daily up to 36.0 mg/day

DRUG

Placebo

Placebo transdermal patch

Trial Locations (7)

Chubu Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region